Cite
HARVARD Citation
Martin, A. et al. (n.d.). P250 Informing the pathway of COPD treatment (the IMPACT study): single inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with COPD – cost-effectiveness in the UK. Thorax. p. A237. [Online].